The Bcl-2-associated death promoter (BAD) lowers the threshold at which the Bcl-2-interacting domain death agonist (BID) triggers mitochondria disintegration

Journal of Theoretical Biology

Volumn 271, Issue 1, 2011, Pages 114-123

  Howells, Christopher C ^a   Baumann, William T ^a   Samuels, David C ^b   Finkielstein, Carla V ^c  

^a State University   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; BAD; Bcl 2; Bifurcation; Modeling

Indexed keywords

PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BID;

APOPTOSIS; BIFURCATION; CONCENTRATION (COMPOSITION); MODELING; NUMERICAL MODEL; PROTEIN; STEADY-STATE EQUILIBRIUM;

APOPTOSIS; ARTICLE; CALCULATION; CONTROLLED STUDY; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMERIZATION; ALGORITHM; ANIMAL; BIOLOGICAL MODEL; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ALGORITHMS; ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; MITOCHONDRIA; MODELS, BIOLOGICAL; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 78650112909     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2010.11.040     Document Type: Article

References (60)

1. Adams J.M., Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007, 26:1324-1337.
2. Ayllon V., Martinez-A C., Garcia A., Cayla X., Rebollo A. Protein phosphatase 1α is a Ras-activated Bad phosphatase that regulates interleukin-2 deprivation-induced apoptosis. EMBO Journal 2000, 19(10):2237-2246.
3. Albeck J.G., Burke J.M., Aldridge B.B., Zhang M., Lauffenburger D.A., Sorger P.K. Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Molecular Cell 2008, 30:11-25.
4. Albeck J.G., Burke J.M., Spencer S.L., Lauffenburger D.A., Sorger P.K. Modeling a snap-action, variable-delay switch controlling extrinsic cell death. PLoS Biology 2008, 6(12):2831-2852.
5. Aldridge B.B., Haller G., Sorger P.K., Lauffenburger D.A. Direct Lyapunov exponent analysis enables parametric study of transient signaling governing cell behaviour. IEE Proceedings-Systems Biology 2006, 153(6):425-432.
6. Berthier A., Lemaire-Ewing S., Prunet C., Monier S., Athias A., Bessede G., Barros J.-P.P.d., Laubriet A., Gambert P., Lizard G., Neel D. Involvement of a calcium-dependent dephosphorylation of Bad associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death and Differentiation 2004, 11:897-905.
7. Bagci E.Z., Vodovotz Y., Billiar T.R., Ermentrout G.B., Bahar I. Bistability in apoptosis: roles of Bax, Bcl-2, and mitochondrial permeability transition pores. Biophysical Journal 2006, 90:1546-1559.
8. Chen C., Cui J., Lu H., Wang R., Zhang S., Shen P. Modeling of the role of a Bax-activation switch in the mitochondrial apoptosis decision. Biophysical Journal 2007, 92:4304-4315.
9. Cheng E.H.-Y.A., Wei M.C., Weiler S., Flavell R.A., Mak T.W., Lindsten T., Korsmeyer S.J. BCL-2 BCL-XL sequesters BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Molecular Cell 2001, 8:705-711.
10. Claerhout S., Decraene D., Laethem A.V., Kelst S.V., Agostinis P., Garmyn M. AKT delays the early-activated apoptotic pathway in UVB-irradiated keratinocytes via BAD translocation. Journal of Investigative Dermatology 2007, 127:429-438.
11. Dillon R.L., White D.E., Muller W.J. The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer. Oncogene 2007, 26:1338-1345.
12. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91:231-241.
13. Datta S.R., Katsov A., Hu L., Petros A., Fesik S.W., Yaffe M.B., Greenberg M.E. 14-3-3 proteinds and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Molecular Cell 2000, 6:41-51.
14. Deprez J., Vertommen D., Alessi D.R., Hue L., Rider M.H. Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascade. Journal of Biological Chemistry 1997, 272(28):17269-17275.
15. Dussmann H., Rehm M., Concannon C.G., Anguissola S., Wurstle M., Kacmar S., Voller P., Huber H.J., Prehn J.H.M. Single-cell quantification of Bax activation and mathematical modelling suggest pore formation on minimal mitochondrial Bax accumulation. Cell Death and Differentiation 2010, 17:278-290.
16. Fahy B.N., Schlieman M.G., Mortenson M.M., Virudachalam S., Bold R.J. Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib. Cancer Chemotherapy and Pharmocology 2005, 56:46-54.
17. Goldsmith K.C., Liu X., Dam V., Morgan B.T., Shabbout M., Cnaan A., Letai A., Korsmeyer S.J., Hogarty M.D. BH3 peptidomimetics potently activate apoptosis and demonstrate single agent efficacy in neuroblastoma. Oncogene 2006, 25:4525-4533.
18. Gilmore A.P., Metcalfe A.D., Romer L.H., Streuli C.H. Integrin-mediated survial signals regulate the apoptotic function of Bax through its conformation and subcellular localization. Journal of Cell Biology 2000, 149:431-445.
19. Hua F., Cornejo M.G., Cardone M.H., Stokes C.L., Lauffenburger D.A. Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: molecular genetic tests on computational model predictions. Journal of Immunology 2005, 175:985-995.
20. Hekman M., Albert S., Galmiche A., Rennefahrt U.E.E., Fueller J., Fischer A., Puehringer D., Wiese S., Rapp U.R. Reversible membrane interaction of BAD requires two C-terminal lipid binding domains in conjunction with 14-3-3 protein binding. Journal of Biological Chemistry 2006, 281(25):17321-17336.
21. Hirai I., Wang H.-G. Survival-factor-induced phosphorylation of Bad results in its dissociation from Bcl-xL but not Bcl-2. Biochemical J. 2001, 359:345-352.
22. Jambal P., Masterson S., Nesterova A., Bouchard R., Bergman B., Hutton J.C., Boxer L.M., Reusch J.E.-B., Pugazhenthi S. Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic B-cells. Journal of Biological Chemistry 2003, 278(25):23055-23065.
23. James E.R., Green D.R. Manipulation of apoptosis in the host-parasite interaction. Trends In Parasitology 2004, 20(6):280-287.
24. Kim Y.M., Kim T.H., Seol D.W., Talanian R.V., Billiar T.R. Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release. Journal of Biological Chemistry 1998, 273:31437-31441.
25. Kuwana T., Bouchier-Hayes L., Chipuk J.E., Bonzon C., Sullivan B.A., Green D.R., Newmeyer D.D. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Molecular Cell 2005, 17:525-535.
26. Law P.T.W., Wong C.-H., Au T.C.C., Chuck C.-P., Kong S.-K., Chan P.K.S., To K.-F., Lo A.W.I., Chan J.Y.W., Suen Y.-K., Chan H.Y.E., Fung K.-P., Waye M.M.Y., Sung J.J.Y., Lo Y.M.D., Tsui S.K.W. The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells. Journal of General Virology 2005, 86:1921-1930.
27. Li H., Zhu H., Xu C.-J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998, 94:491-501.
28. Letai A., Bassik M.C., Walensky L.D., Sorcinelli M.D., Weiler S., Korsmeyer S.J. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002, 2:183-192.
29. Luo X., Buhihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl2 interacting protein mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998, 94:481-490.
30. Liu Y., Storm D.R. Dephosphorylation of neuromodulin by calcineurin. Journal of Biological Chemistry 1989, 264(22):12800-12804.
31. Nicholson D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death and Differentiation 1999, 6:1028-1042.
32. Nechushtan A., Smith C.L., Lamensdorf I., Yoon S.-H., Youle R.J. Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. Journal of Cell Biology 2001, 153(6):1265-1276.
33. Nicholson K.M., Anderson N.G. The protein kinase B/Akt signalling pathway in human malignancy. Cellular Signalling 2002, 14:381-395.
34. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74:609-619.
35. Obata T., Yaffe M.B., Leparc G.G., Piro E.T., Maegawa H., Kashiwagi A., Kikkawa R., Cantley L.C. Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. Journal of Biological Chemistry 2000, 275(46):36108-36115.
36. Peso L.D., Gonzalez-Garcia M., Page C., Herrera R., Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997, 278:687-689.
37. Rehm M., Huber H.J., Dussman H., Prehn J.H. Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. Embo Journal 2006, 25:4338-4349.
38. Shibasaki F., Kondo E., Akagi T., McKeon F. Suppression of signaling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 1997, 386:728-731.
39. Shinoad S., Schindler C.K., Quan-Lan J., Saugstad J.A., Taki W., Simon R.P., Henshall D.C. Interaction of 14-3-3 with Bid during seizure-induced neuronal death. Journal of Neurochemistry 2003, 86:460-469.
40. Saito A., Hayashi T., Okuno S., Ferrand-Drake M., Chan P.H. Overexpression of copper/zinc superoxide dismutase in transgenic mice protects against neuronal cell death after transient focal ischemia by blocking activation of the Bad cell death signaling pathway. Journal of Neuroscience 2003, 23(5):1710-1718.
41. Saito S., Hiroi Y., Zou Y., Aikawa R., Toko H., Shibasaki F., Yazaki Y., Nagai R., Komuro I. Β-adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes. Journal of Biological Chemistry 2000, 275(44):34528-34533.
42. Springer J.E., Azbill R.D., Nottingham S.A., Kennedy S.E. Calcineurin-mediated Bad dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury. Journal of Neuroscience 2000, 20(19):7246-7251.
43. Saito M., Korsmeyer S.J., Schlesinger P.H. BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nature Cell Biology 2000, 2:553-555.
44. Strasser A., Huang D.C., Vaux D.L. Biochimica et Biophysica Acta 1997, 1333:151-178.
45. Sedlak T.W., Oltvai Z.N., Yang E., Wang K., Boise L.H., Thompson C.B., Korsmeyer S.J. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proceedings of the National Academy of Sciences 1995, 92:7834-7838.
46. Spencer S.L., Gaudet S., Albeck J.G., Burke J.M., Sorger P.K. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature Letters 2009, 459:428-433.
47. Tan Y., Ruan H., Demeter M.R., Comb M.J. p90RSK blocks Bad-mediated cell death via a protein kinase C-dependent pathway. Journal of Biological Chemistry 1999, 274(49):34859-34867.
48. Valentijn A.J., Metcalfe A.D., Kott J., Streuli C.H., Gilmore A.P. Spatial and temporal changes in Bax subcellular localization during anoikis. Journal of Cell Biology 2003, 162:599-612.
49. Won J., Kim D.Y., La M., Kim D., Meadows G.G., Joe C.O. Cleavage of 14-3-3 protein by caspase-3 facilitates Bad interaction with Bcl-x(L) during apoptosis. Journal of Biological Chemistry 2002, 278(21):19347-19351.
50. Wei M.C., Lindsten T., Mootha V.K., Weiler S., Gross A., Ashiya M., Thompson C.B., Korsmeyer S.J. tBid, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes and Development 2000, 14:2060-2071.
51. Wang K., Yin X.-M., Chao D.T., Milliman C.L., Korsmeyer S.J. BID: a novel BH3 domain-only death agonist. Genes and Development 1996, 10:2859-2869.
52. Wang H.-G., Pathan N., Ethell I.M., Krajewski S., Yamaguchi Y., Shibasaki F., McKeon F., Bobo T, Franke T.F., Reed J.C. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 1999, 284:339-343.
53. Wolff D.J., Sved D.W. The divalent cation dependence of bovine brain calmodulin-dependent phosphatase. Journal of Biological Chemistry 1985, 260(7):4195-4202.
54. Yi X., Yin X.-M., Dong Z. Inhibition of Bid-induced apoptosis by Bcl-2. Journal of Biological Chemistry 2003, 278(19):16992-16999.
55. Yang E., Zha J., Jockel J., Boise L.H., Thompson C.B., Korsmeyer S.J. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell 1995, 80:285-291.
56. Yin X.M., Oltvai Z.N., Korsmeyer S.J. BH1 and BH2 domains of Bcl-2 are required for hinhibition of apoptosis and heterodimerization with Bax. Nature 1994, 369:321-323.
57. Yaffe M.B., Rittinger K., Volinia S., Caron P.R., Aitken A., Leffers H., Gamblin S.J., Smerdon S.J., Cantley L.C. The structural basis for 14-3-3: phosphopeptide binding specificity. Cell 1997, 91:961-971.
58. Zhou X.-M., Liu Y., Payne G., Lutz R.J., Chittenden T. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155. Journal of Biological Chemistry 2000, 275(32):25046-25051.
59. Zha J., Harada H., Yang E., Jockel J., Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell 1996, 87:619-628.
60. Zhou G.-L., Zhuo Y., King C.C., Fryer B.H., Bokoch G.M., Field J. Akt phosphorylation of Serine 21 on Pak1 modulates Nck binding and cell migration. Molecular and Cellular Biology 2002, 23(22):8058-8069.